rybrevant.com
Summary
The website provides information about RYBREVANT®, a medication approved for the treatment of advanced non-small cell lung cancer (NSCLC) with specific EGFR mutations.
Associated Brands
IAB Categories
Health & Fitness
IAB Ad Products
Health and Medical ServicesPharmaceuticals
Tags
Creatives
| ID | Domain | Seat | Bid | Timestamp | Status | Ad Format | Sub Format | Size | Quality Score | Data Transferred | Computational Cost |
|---|---|---|---|---|---|---|---|---|---|---|---|
| cmhy9z | DInt | $8.26 | 11/14/2025, 3:05:20 AM | Ad Analysis: Success Domain Analysis: Success Ad Rendering: Success Brand Mapping: Success Domain Capture: Failed | banner | - | 320x50 | 6/10 | 1317.32 KB | 8857.00 ms |